Latest news and press releases about OraSure Technologies, Inc. (OSUR): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions.
Price
| Price | $3.49 |
| Market Cap | $240M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.73 |
| EV / EBITDA | -2.07 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -14.73% |
| Return on Invested Capital | -14.90% |
| Return on Assets | -13.63% |
| Gross Margin | 41.38% |
| Operating Margin | -44.75% |
| Net Margin | -43.70% |
Related companies: CATX · GNFT · NAUT · NTHI · NYXH · PRE · PROF
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of OSUR: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks